Angiotensin II (Ang II) is locally generated in the placenta and regulates syncytial transport, vascular contractility and trophoblast invasion. It acts through two receptor subtypes, AGTR1 and AGTR2 (AT1 and AT2), which typically mediate antagonising actions. The objectives of this study are to characterise the cellular distribution of AGTR1 and AGTR2 at the maternal-fetal interface and explore the effects on cytotrophoblast turnover. Low levels of AGTR2 mRNA were detected in first trimester placental homogenates using real-time PCR. Immunohistochemistry using polyclonal antibodies against AGTR1 and AGTR2 detected the receptors in first trimester placenta, decidua basalis and villous tip outgrowths in culture. Serial staining with cytokeratin-7 was used to identify extravillous trophoblasts (EVTs). AGTR1 was found in the syncytiotrophoblast microvillous membrane, in a subpopulation of villous cytotrophoblasts, and in Hofbauer cells. AGTR1 was strongly upregulated in cytotrophoblasts in cell columns and villous tip outgrowths, but was absent in interstitial and endovascular EVTs within the decidua. AGTR2 immunostaining was present in Hofbauer cells and villous cytotrophoblasts, but was absent from syncytiotrophoblast. Faint staining was detected in cell column cytotrophoblasts and villous outgrowths, but not in EVTs within the decidua. Both receptors were detected in placental homogenates by western blotting. Ang II significantly increased proliferation of cytotrophoblasts in both villous explants and villous tip outgrowths, but did not affect apoptosis. Blockade of AGTR1 and AGTR2 together abrogated this effect. This study shows specific expression patterns for AGTR1 and AGTR2 in distinct trophoblast populations at the maternal-fetal interface and suggests that Ang II plays a role in placental development and generation of EVTs.
Introduction
Normal development of the villous placenta in early pregnancy, and coincident colonisation of the maternal decidua by extravillous trophoblasts (EVTs), is essential to a healthy pregnancy. Insufficient growth and development of the villous tree reduces the gaseous and nutrient transfer capacity of the placenta and can lead to fetal growth restriction (FGR), while shallow EVT invasion and impaired remodelling of uterine spiral arteries predispose to pre-eclampsia and FGR. Angiotensin II (Ang II), the main effector molecule of the renin-angiotensin system, is locally generated in the placenta (Hosokawa et al. 1985 , Cooper et al. 1999 and decidua (Shaw et al. 1989) , suggesting actions in regulating placental development. Indeed, many of the well-known actions of Ang II, including regulation of vascular contractility, osmoregulation (Peach 1981) , cellular proliferation (Dinh et al. 2001) , angiogenesis (Le Noble et al. 1991) and apoptosis (Yamada et al. 1996) , are key processes for placental development and function.
Recent studies provide evidence for an important regulatory role for Ang II in trophoblast invasion during early placentation. In vitro studies using a transformed cytotrophoblast cell line (HTR-8/SVneo) demonstrated a potent inhibition of invasive potential, which is abrogated by selective inhibition of type 1 (AGTR1, AT1) receptor signalling (Xia et al. 2002) . The physiological significance of this result was supported by a recent report demonstrating Ang II stimulates proliferation, but inhibits differentiation, of cytotrophoblast cells from first trimester villous tip outgrowths in culture (Araki-Taguchi et al. 2008 ). Ang II is therefore an attractive candidate for mediating the shallow decidual invasion and impaired vascular remodelling in pre-eclampsia and FGR. Greater understanding of the signalling pathways used during vascular remodelling is essential to delineate Ang II actions in regulating EVT invasion in vivo.
In humans, Ang II actions are mediated through two receptor subtypes, AGTR1 and AGTR2 (AT1 and AT2) receptors, with the AGTR2 receptor generally opposing the actions of AGTR1 (De Gasparo et al. 2000) . AGTR1 expression has been demonstrated in villous placenta throughout gestation, localised to syncytiotrophoblast and cytotrophoblast, Hofbauer cells and peri-vascular cells (Li et al. 1998 , Cooper et al. 1999 , Williams et al. 2010 . A low degree of AGTR2-specific binding of radiolabelled Ang II in placental homogenates provided evidence for low expression of the receptor (Li et al. 1998) , but studies using conventional RT-PCR have failed to confirm this finding (Cooper et al. 1999) . A recent study has reported AGTR2 mRNA expression in placental homogenates using real-time PCR and protein expression by immunohistochemistry (Williams et al. 2010) .
Despite evidence suggesting a role for both the receptors in the origins of pre-eclampsia and FGR (Plummer et al. 2004 , Tower et al. 2006 , Xia et al. 2007 , comprehensive localisation studies of the AGTR1 and AGTR2 receptors in human placental EVT populations during early pregnancy have not been conducted. Interactions between AGTR1 and AGTR2 have been previously described, through the formation of heterodimers (AbdAlla et al. 2001 ) and the interaction between the two receptors in other tissues is antagonistic in terms of both opposing function and cellular signalling (Dinh et al. 2001) . Therefore, determining the balance and inter-relationships between AGTR1 and AGTR2 in distinct villous and extravillous trophoblast populations at the maternal-fetal interface is critical to understand their potential functions in normal and pathological pregnancies.
The objectives of this study are a) to confirm the presence of the AGTR2 receptor in first trimester human placenta using real-time PCR techniques and immunohistochemistry, b) to conduct detailed localisation studies of both AGTR1 and AGTR2 receptors at the early pregnancy maternal-fetal interface and c) to investigate the effect of Ang II on villous and extravillous trophoblast cell turnover.
Results

AGTR2 mRNA expression by first trimester placenta
Real-time PCR using SYBR green identified the presence of AGTR2 mRNA in ten first trimester placental homogenates (nZ15). Although quantification was not conducted, fluorescence levels were low. The cycle threshold (C t ) for detection of AGTR2 mRNA in myometrial samples was typically 24-26, but that for placenta was 30-32 ( Fig. 1A and B) . PCR products were subsequently subjected to agarose gel electrophoresis, demonstrating that, as suspected, most placental samples (nZ11) had expression levels too low for detection by ethidium bromide (Fig. 1C) . 
Immunolocalisation of AGTR1 and AGTR2
Immunohistochemical protocols were optimised on formalin-fixed paraffin tissue sections enabling clear delineation of distinct cytotrophoblast cell subpopulations. The specificity of immunostaining was confirmed by the inclusion of adult mouse (for AGTR1) and fetal (for AGTR2) kidney sections, demonstrating specific localisation patterns in accordance with previous publications ( Fig. 2A and B ; Ozono et al. 1997 , Miyata et al. 1999 . Pre-adsorption of both antibodies with the appropriate peptide resulted in a complete absence of staining in both placental and kidney tissues (Figs 2C, D, H, L and 3C) .
AGTR1 localisation
In villous placenta, AGTR1 was localised specifically to the apical microvillous membrane of syncytiotrophoblast, with fainter staining in a subpopulation (w20-30%) of villous cytotrophoblasts (Fig. 2E ). Hofbauer cells in the villous core exhibited intense membrane immunostaining (Fig. 2F) . No staining was detected in vascular endothelial cells of capillaries and larger central vessels (Fig. 2G) .
In contrast to the relatively weak staining in villous cytotrophoblasts, AGTR1 was strongly upregulated in cytotrophoblasts in cell columns ( Fig. 3A and B) , and in those EVTs detaching from the column and entering the decidua ( Fig. 3D 0 and E 0 ). EVTs within the decidual stroma were identified by immunostaining serial sections for cytokeratin-7 (CK-7; Fig. 3F and G). AGTR1 was markedly absent from interstitial EVTs and endovascular/mural EVTs surrounding and lining decidual vessels (Fig. 3F 0 and G 0 ). Decidual stromal and epithelial cells were strongly positive for AGTR1.
AGTR2 localisation
Unlike AGTR1, AGTR2 immunostaining was absent from the syncytiotrophoblast, but present in the underlying layer of villous cytotrophoblasts (Fig. 2I-K) . Hofbauer cells exhibited intense membrane staining, while vascular endothelial cells were negative for AGTR2 (Fig. 2I) . Faint heterogeneous immunostaining for AGTR2 was detected in cytotrophoblasts in the cell column ( Fig. 4A and B) . Decidualised stromal cells were strongly immunopositive for AGTR2, but as for AGTR1, interstitial or endovascular EVTs within the decidua were conspicuous by their lack of staining ( Fig. 4C 0 and D 0 ). Decidual epithelial glands exhibited patchy staining for AGTR2 (Fig. 4C 0 ).
Villous tip outgrowths
EVTs generated by performing outgrowths from villous tips cultured on collagen were strongly and homogeneously positive for AGTR1 ( Fig. 5B and D) . AGTR2 immunostaining was detected in EVT outgrowths distal to the villous tip (Fig. 5F ).
Western blots
A signal of 44 kDa, corresponding to AGTR1 receptor, was detected in 3T3 and SGHPL-4 cells (kindly provided by Prof. Guy Whitley, St George's Hospital Medical School) and in placental homogenates from the first trimester of pregnancy (7-12 weeks, nZ5). Representative blots are shown in Fig. 6A . This band was abolished by pre-adsorption of the AGTR1 antibody with a fivefold excess of blocking peptide, confirming specificity. A strong band of 55 kDa was detected when using the AGTR2 antibody in myometrial homogenate, while no signal was detected in HepG2 cells. A faint band of the same size was detected in placental homogenates (7-12 weeks gestation, nZ5; Fig. 6B ). This band was greatly diminished by peptide pre-adsorption. All membranes were stripped and reprobed for b-actin for a protein loading control.
Effect of Ang II on villous and extravillous trophoblast cell turnover
Proliferation of cytotrophoblast cells in villous outgrowths was examined by BrdU incorporation. Positively stained nuclei were detected in the cytotrophoblasts in the villous tip and in the cell column of the outgrowths (Fig. 7C ). Occasional stromal cells were BrdU positive. Substitution of the primary antibody with mouse IgG resulted in an absence of staining (inset, Fig. 7C ). Treatment of villous outgrowths (nZ5-7) with Ang II (10 K7 M) significantly stimulated the proliferation of cell column cytotrophoblast cells (Fig. 7A ). There was a trend for Ang II (10 K6 M) to stimulate proliferation (PZ0.313). This effect was abolished by co-treatment with the AGTR1 and AGTR2 inhibitors CS (candesartan) and PD (PD123319) in combination (nZ3-6; Fig. 7B ). Co-treatment with CS did not consistently inhibit the stimulatory effect of Ang II. The effect of Ang II on apoptosis in villous tip outgrowths was examined by immunostaining for CK-18 cleavage product (M30) and TUNEL staining (nZ3-5). Positively stained cytotrophoblasts were primarily located adjacent to the villous tip, with occasional apoptotic cells in the cell column (Fig. 7E) . A very similar pattern was detected with TUNEL staining (Fig. 7F) . Substitution of M30 antibody with MIgG or omission of terminal deoxynucleotidyl transferase (TdT) resulted in an absence of staining (insets, Fig. 7E and F). Ang II had no effect on apoptosis as monitored by either method ( Fig. 7D, M30 ; TUNEL data not shown).
In villous explants, Ang II (10 K6 M) significantly increased cytotrophoblast proliferative index compared with control levels as assessed by Ki67 immunostaining (nZ5-7; P!0.05) and BrdU incorporation (nZ3-10; P!0.01; Fig. 8A and B). Lower concentrations had no effect. Co-treatment with AGTR1/AGTR2 inhibitors non-significantly reduced the proliferative index (nZ3, Fig. 8C ). Apoptotic nuclei were detected primarily in the syncytiotrophoblast layer, but also in underlying cytotrophoblast cells. Ang II had no effect on the apoptotic index as assessed by immunostaining for cytokeratin M30 (Fig. 8D ) or TUNEL staining (data not shown; nZ4-6 placentas). Representative images of villous cytotrophoblast BrdU incorporation and TUNEL staining are shown in Fig. 8E and F.
Discussion
Until recently, immunohistochemical studies of Ang II receptors have been hampered by a lack of specific, high-affinity antibodies (Cooper et al. 1999 , Laskowska et al. 2003 , Thapa et al. 2004 . We confirmed the presence of receptor AGTR2 in the first trimester human placenta, using molecular techniques, immunohistochemistry and western blotting. We have also described the expression of AGTR1 and AGTR2 in trophoblast subpopulations at the maternal-fetal interface, with AGTR1 primarily expressed by the differentiated trophoblasts:syncytiotrophoblast and cell column extravillous trophoblasts, and AGTR2 by proliferating villous cytotrophoblasts. AGTR2 is abundantly expressed in murine, porcine and bovine placenta (Grady et al. 1991 , Nielsen et al. 1996 , Schauser et al. 1998 , and it is the predominant receptor present in human cycling endometrium and myometrium (Tsuzuki et al. 1994 , Ahmed et al. 1995 . However, previous reports in the literature of its expression in human placenta are conflicting (Cooper et al. 1999 , Anton et al. 2008 , Williams et al. 2010 . In this study, AGTR2 transcripts were detected in 10/15 placental samples using SYBR green detection, while a signal was only detected in 4/15 samples using electrophoresis with ethidium bromide detection. The localisation of AGTR2 to villous cytotrophoblasts and Hofbauer cells, both of which are sparser per unit area of term placenta, may explain the failure of previous studies to detect the receptor in whole tissue placental homogenates later in gestation (Cooper et al. 1999 , Anton et al. 2008 . Its presence in human placenta is consistent with the observation of AGTR2-dependent contraction of term chorionic plate artery vascular smooth muscle (Benoit et al. 2008 ) and low but significant AGTR2 inhibitory binding of radiolabelled Ang II to term placenta (Li et al. 1998) .
Although the presence of AGTR1 in the human placenta has been previously reported (Li et al. 1998 , Cooper et al. 1999 either used antibodies at very high concentrations (Cooper et al. 1999 , Laskowska et al. 2003 or used frozen tissue sections (Thapa et al. 2004) , which have poor morphology, thereby making distinctions between individual cell types problematic. The specific localisation to the apical microvillous membrane of the syncytiotrophoblast is consistent with the inhibition of the system A amino acid transporter (Shibata et al. 2006) , and the stimulation of placental lactogen and 17b-estradiol synthesis by exogenous Ang II (Kalenga et al. 1994 (Kalenga et al. , 1995 This study has demonstrated that high concentrations of Ang II significantly increase villous cytotrophoblast proliferation (assessed by BrdU incorporation and Ki67 immunostaining), but do not affect apoptosis (measured by CK-18 cleavage and TUNEL). Blockade of AGTR1 and AGTR2 together reduces cytotrophoblast proliferation index. The only previous report of Ang II actions on villous placental explants shows enhanced proliferation and reduced apoptosis, but does not describe the cell types involved (Williams et al. 2010) . The discrepancy in the effect on apoptosis is likely to be due to the use of different methodologies and to the low sample number (nZ1-3) used by Williams et al. (2010) . Together, these data support that Ang II has regulatory actions on first trimester placental development.
The distinct pattern of AGTR1 staining in the medial and distal cytotrophoblast columns and EVTs entering the decidua, but not in deeper interstitial, endovascular or intramural EVT, suggests that the AGTR1 receptor plays a role in early EVT differentiation. It appears that this receptor is acquired as cells exit the cell cycle after proliferating at the base of the columns. Uniform expression in columns in explant cultures is consistent with this view, because in this system cells exit the cell cycle after 24-36 h (Aplin et al. 1999) . AGTR2 exhibits a similar expression profile in vivo and in vitro, although it appears to be less abundant. A previous study of the first trimester placental explants suggested that Ang II increased EVT outgrowth and the number of cells in the columns (Araki-Taguchi et al. 2008) . Increased PAI1 and MMP2 mRNA, but absence of a1 integrin expression, was observed in the outgrowths. Our finding of increased BrdU incorporation with Ang II treatment support these observations. Moreover, the abolition of this effect by co-treatment with the AGTR1 and AGTR2 receptor blockers suggests that signalling through both the receptors is responsible for this effect, which is consistent with the co-expression of the receptors by cell column cytotrophoblasts. The striking absence of AGTR1 and AGTR2 in EVTs within the decidual stroma and spiral arteries indicates that Ang II is not involved in EVTmediated vascular remodelling. This is an important advance in the field and pinpoints the actions of Ang II in regulating EVT differentiation and entry into the decidua rather than in later invasion events. Decidua is a significant source of extra-renal Ang II production, and the co-expression of both AGTR1 and AGTR2 by decidual stromal cells suggests auto-and paracrine actions in regulating decidual and placental development and function , Herse et al. 2007 ). Genetic studies have suggested a role for AGTR1 in FGR and pre-eclampsia (Plummer et al. 2004 , Tower et al. 2006 . It is tempting to speculate that its transient upregulation in cell columns is a requirement for successful trophoblast invasion, and that its failure may play a role in the pathogenesis of pregnancy complications. Excessive or sustained stimulation of AGTR1 on EVTs, or activation of AGTR1 by auto-antibodies (Xia et al. 2003 ) may contribute to the reduced EVT colonisation of the decidua.
In summary, AGTR1 and AGTR2 expression occurs in distinct trophoblast populations. Antagonistic roles are well established, and our localisation data suggest that AGTR2 may be associated with the restriction of villous cytotrophoblast to a proliferative or progenitor status. Transient expression of AGTR1 in a minority of villous cytotrophoblasts, and in cell column cytotrophoblasts, is consistent with the roles in early differentiation in both lineages. The absence of AGTR1 and AGTR2 expression by interstitial and endovascular EVTs rules out the actions of Ang II in modulating EVT invasion or remodelling through these receptors. We report stimulatory action of Ang II on villous and extravillous trophoblast proliferation, which is inhibitory by dual blockade of AGTR1 and AGTR2. Ang II mediates angiogenesis (Khakoo et al. 2008) (Kagami et al. 1994 , Chua et al. 1998 , Tower et al. 2005 . Defining the functions of Ang II in pregnancy pathologies and the mechanisms of regulation of receptor expression in placenta remain future challenges.
Materials and Methods
Tissue collection
First trimester placental and decidual samples (nZ25) were collected from women undergoing elective surgical and medical termination of pregnancy between 7 and 12 weeks gestation. Written informed consent was obtained from all women and this study was approved by the Central Manchester Regional Ethics Committee (03/CM/31). Tissue samples were obtained within 30 min of surgery and macroscopically dissected to separate villous placenta and maternal decidua. Portions of each (w0.5-1 cm 2 ) were fixed in 10% neutral buffered formalin for either 30 min or 24 h at 4 8C, prior to thorough washing in Tris-buffered saline (TBS) and routine paraffin embedding. In all, 5 mm sections were cut on to poly-L-lysine (Sigma)-coated microscope slides for immunohistochemistry. A further portion of the placenta was immersed in RNALater (Applied Biosystems, Foster City, CA, USA), prior to RNA extraction using Absolutely RNA RT-PCR Mini prep kit (Stratagene, La Jolla, CA, USA), including a DNase step, according to the manufacturer's instructions.
Real-time PCR
RNA was quantified using the Ribogreen assay (Invitrogen Ltd), with reference to rRNA standards. cDNA was generated from 500 ng RNA using StrataScript First-Strand Synthesis System (Stratagene) following the manufacturer's protocol.
As previous literature suggested that detection of the AGTR2 receptor mRNA may be problematic (Cooper et al. 1999) , real-time PCR using SYBR green was conducted as this detects lower levels of expression compared with the previously conducted ethidium visualisation. Primers (forward AT2MX1, 5 0 -GCT ATG GGA AGA ACA GGA TAA C-3 0 , and reverse AT2MX2, 5 0 -TCC TTC ACG GTC CAG TTA C-3 0 ) were designed using Beacon Designer (Premier Biosoft, Palo Alto, CA, USA) and were located within exon 3 of the AGTR2 receptor gene. Primers were Blast searched (http://www.ncbi.nlm.nih.gov/ blast/Blast). The presence of splice variants (Wharton et al. 1997 , Nishimura et al. 1999 ) and the small sizes of exons 1 and 2 meant that it was not possible to design exon-spanning primers. Thus, negative controls of extracted, but not reverse transcribed, RNA samples were subjected to the PCR protocol to exclude genomic DNA contamination. Realtime PCR was conducted on the MX4000 thermal cycler (Stratagene) using Brilliant QPCR SYBR Green QPCR Master Mix (Stratagene). Samples underwent denaturation at 95 8C for 10 min, followed by 40 cycles at 95 8C for 30 s, 56 8C for 1 min and 72 8C for 30 s, followed by the generation of the melting curve at 95 8C for 1 min and 56 8C for 30 s. All PCRs were conducted in duplicate with negative controls on the same plate. cDNA generated from myometrium was used as a positive control. PCR products were subsequently subjected to 1% agarose gel electrophoresis using ethidium bromide visualisation.
Immunohistochemistry for AGTR1 and AGTR2 in villous placenta AGTR1 and AGTR2 subtypes were immunolocalised in 5 mm sections of placenta. For AGTR1, sections of the placental tissue fixed for 24 h were dewaxed in xylene and rehydrated through descending grades of ethanol. Endogenous peroxidise activity was inhibited by treatment with 3% hydrogen peroxide (BDH Chemical Ltd, Poole, UK) prior to application of a nonimmune block (10% normal swine serum (Sigma), 2% human serum ('in house') and 0.1% Tween-20 (Bio-Rad) in TBS) for 30 min. The primary antibody, rabbit polyclonal antibody directed against the N-terminal extracellular domain of human AGTR1 (sc-1173; Santa Cruz Biotechnology, Santa Cruz, CA USA), was diluted to 5 mg/ml and applied to sections overnight at 4 8C. Thereafter, antibody binding was detected by the sequential application of biotinylated swine anti-rabbit IgGs (Dako, Ely, UK) and avidin-peroxidase conjugate (Sigma). The chromogen diaminobenzidine (Sigma) was applied for 5 min, followed by counterstaining with Harris' haematoxylin and differentiation with acid alcohol. Sections were dehydrated through ascending grades of ethanol, cleared with xylene and mounted with DPX (BDH).
For AGTR2, sections of the placental tissue fixed for 30 min were used. A similar protocol was followed, with the following exceptions. The non-immune block contained rabbit, rather than swine, serum. The primary antibody was a goat polyclonal antibody directed against the N-terminal extracellular domain of human AGTR2 (sc-7421, Santa Cruz Biotechnology) diluted to 7 mg/ml. Secondary antibody was biotinylated rabbit antigoat IgG (Dako).
Rat adult and fetal kidney were used as positive controls, and antibodies were pre-adsorbed with a fivefold excess of blocking peptide to serve as a negative control. Both antibodies have previously been used to immunolocalise AGTR1 and AGTR2 receptors in human colonic mucosa (Hirasawa et al. 2002) and rat kidney (Miyata et al. 1999) .
Identification of AGTR1 and AGTR2 in EVTs
To identify decidua basalis (containing invasive EVTs), immunohistochemistry was performed for CK-7. A similar protocol as described above was used with the following alterations. Antigen retrieval was performed by microwaving for 2!5 min in 0.01 M sodium citrate buffer (pH 6.0). The non-immune block contained 10% normal goat serum (Sigma), 2% human serum and 0.1% Tween-20 in TBS. The primary antibody, mouse monoclonal directed against CK-7 (Dako), was diluted to 0.5 mg/ml in non-immune block.
Owing to differences in fixation and antigen retrieval methods for all the antibodies, it was not possible to use dual immunohistochemistry to investigate co-localisation of CK-7 with AGTR1 and AGTR2. Instead, 5 mm serial sections were immunostained for CK-7 and AGTR1 or AGTR2, using identical protocols as described for villous placenta. These experiments were performed on decidua basalis samples (nZ7) exhibiting endovascular and interstitial EVT invasion, identified by prior CK-7 immunostaining.
Villous tip outgrowths
First trimester placentae were washed in warmed 1:1 mix of DMEM and Ham's F12 (DMEM/F12, Invitrogen), containing 1% penicillin, streptomycin and L-glutamine (PSG, Sigma) and terminal portions of villi with trophoblast cell columns were selected and separated under a dissecting microscope as previously described (Aplin et al. 1999) . Villous tips were seeded onto collagen gels prepared in advance using 1 ml of rat tail collagen (4 mg/ml; BD Biosciences, Oxford, UK) mixed with 50 ml of culture medium, followed by 100 ml of 7.5% NaHCO 3 . As the collagen polymerised, 100 ml was aliquotted into each well of a 24-well culture plate and left to set at 37 8C for 30 min. One villous tip was transferred to the gel surface using fine forceps, surrounded by culture medium and allowed to attach overnight at 37 8C, under 3% O 2 . Attachment was assessed w16 h later, by the appearance of radial stress lines in the collagen gel, at which point 1 ml of medium was added to cover each villous tip. Villi were left in culture for 48 h, then fixed in 10% neutral buffered formalin for 24 h, processed to paraffin blocks and cut sections were stained for CK-7, AGTR1 and AGTR2 as described above.
Microscopy
A Leitz Dialux 22 microscope was used in conjunction with a QI Cam Fast 1394 camera and Image Proplus 6.0 imaging system for photography and analysis of immunostaining.
Western blotting
To confirm the specificity of the antibodies and the expression of AGTR1 and AGTR2 protein by the first trimester placenta, western blotting analysis was performed on first trimester placental lysates, with appropriate positive controls (AGTR1: 3T3 and PL-4 cells; AGTR2: myometrium and HepG2 cells). Placental tissue was washed in cold PBS then homogenised on ice in RIPA buffer (Tris 50 mM, NaCl 150 mM, SDS 0.1%, sodium deoxycholate 0.5%, NP40 1%) with the addition of 10 ml/10 ml protease inhibitor cocktail (set 1; VWR, East Grinstead, UK). Samples were centrifuged at 17 600 g, at 4 8C for 10 min and the supernatant was stored at K80 8C. Protein content was determined using the standardised Commercial Bradford Assay (Bio-Rad).
For AGTR1, 15 mg placental lysate were reduced using b-mercaptoethanol prior to loading on a 12% polyacrylamide gel and were separated using SDS-PAGE at 200 V for 3.5 h. For AGTR2, 60 mg placental lysate were reduced using b-mercaptoethanol and heated at 95 8C for 5 min, then stored overnight at K20 8C prior to loading and were subjected to electrophoresis like AGTR1. Proteins were then transferred to a nitrocellulose membrane (Hybond ECL, Amersham Biosciences) using electro-transfer. Membranes were blocked in 3% BSA for 2 h at room temperature, then probed with primary antibodies for AGTR1 (sc-1173, Santa Cruz Biotechnology, 0.2 mg/ml) and AGTR2 (sc-7421, Santa Cruz Biotechnology, 1 mg/ml) overnight at 4 8C. After thorough washing in TBS-Tween (TBS 0.05% Tween-20), membranes were incubated with HRP-conjugated secondary antibodies (0.2 mg/ml, Dako) for 1.5 h at room temperature. After further washes, bands were visualised on photosensitive film (Amersham Biosciences) using ECL reagents (ECL1: 2.5 mM luminol, 1.1 mM p-coumaric acid, 0.1 M Tris pH 8.5; ECL2: 0.02% hydrogen peroxide, 0.1 M Tris pH 8.5). Antibody specificity was verified by pre-adsorption with 5! peptide block overnight at 4 8C prior to applying to the membranes. To confirm protein loading, membranes were stripped in 62.5 mM Tris-HCl, 2% w/v SDS and 100 mM b-mercaptoethanol pH 6.7 for 40 min by agitating at 50 8C and reprobed using mouse MAB to b-actin (Sigma, 0.2 mg/ml). Villous explants (w3 mm 3 , nZ10 placentas) were dissected and cultured in DMEM/F12 containing 1% PSG. After 24 h, Ang II (10 K6 -10 K8 M) and 100 mM BrdU were added in culture medium and explants were cultured for a further 48 h. Villous outgrowths (nZ10 placentas) were generated as above, with Ang II (10
K6
-10 K8 M) treatment from 18 h for a further 72 h. In a subgroup of explants and outgrowths, selective AGTR1 (candesartan, 10 K6 M; Takeda Pharmaceuticals, Osaka, Japan) and AGTR2 (PD123319, 10 K6 M; Pfizer Ltd, Sandwich, UK) inhibitors were added in the presence and absence of Ang II (10 K7 M; nZ3 placentas). At the end of the culture period, explants and outgrowths were fixed in 10% neutral buffered formalin, wax embedded and subjected to immunohistochemistry for proliferating (Ki67, BrdU) and apoptotic cells (cytokeratin M30). A similar protocol was used as described for AGTR1/AGTR2 with the following exceptions. To detect proliferating cells, tissue sections were microwaved in 0.01 M sodium citrate (pH 6.0) for 10 min, followed by incubation in a non-immune block comprising 10% normal goat serum, 2% human serum and 0.1% Tween-20 in TBS. Mouse monoclonal anti-Ki67 (Dako) was applied at 0.6 mg/ml. Proliferation was also assessed by BrdU incorporation; sections were pretreated with 2 M HCl and 0.1% trypsin at 37 8C, prior to application of monoclonal anti-BrdU (Sigma) diluted to 3 mg/ml in 5% BSA. Apoptosis was detected by immunostaining for the cytokeratin M30 neoepitope using a monoclonal anti-M30 (Roche) at 1 mg/ml. In all cases, the secondary antibody was biotinylated with goat anti-mouse IgG (Dako). Negative controls were performed by substitution of primary antibody with non-immunised mouse IgG. TUNEL staining was performed using the In Situ Cell Death Detection kit with peroxidase detection (Roche) as described previously (Heazell et al. 2008 ) on a subgroup of explants and outgrowths (nZ3-5) to confirm the apoptosis data. Application of dUTP in the absence of TdT was performed as a negative control.
Quantification of cell turnover
Ten fields of view of each tissue section were imaged. Cells positive for Ki67, BrdU and M30 were manually counted and the total nuclear count was quantified using image analysis software or by manual counting. The proliferative/apoptotic index is a ratio of the number of positive cells over the total nuclear count. All data were expressed as fold change from control to overcome inherent variability in the basal proliferation/apoptotic index. Statistical analyses were performed using Graphpad Prism, using Wilcoxon signed rank tests to determine the significance of changes in cell turnover compared with basal levels.
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